Craft
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
banner
Allergy Therapeutics financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.

Stock Price

£0.1

2024-10-29

Market Capitalization

£252.6 M

2024-10-29

Revenue

£55 M

FY, 2025

CreditSafe Score

?
Score changed on Jul 19, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn more

Financial Statements

GBPFY, 2018FY, 2019FY, 2020FY, 2021FY, 2022FY, 2023FY, 2024FY, 2025
Revenue68.3M73.7M78.2M84.3M72.8M59.6M55.2M55.0M
Cost of goods sold14.8M16.3M16.3M18.0M19.1M22.1M25.5M25.7M
Gross profit54.2M58.0M62.6M66.9M54.4M38.3M31.3M30.5M
Gross profit margin, %79.3%78.7%80.0%79.4%74.8%64.3%56.6%55.5%
Operating expense total58.0M50.9M48.6M60.8M64.5M72.9M62.4M54.6M
Depreciation and amortization2.2M2.1M3.9M4.1M4.2M4.2M4.3M4.2M
EBITDA(3.8M)7.1M14.0M6.2M(10.0M)(34.5M)(31.1M)(24.1M)
EBITDA margin, %-5.6%9.6%17.9%7.3%-13.8%-58.0%-56.4%-43.8%
EBIT(6.1M)5.0M10.1M2.0M(14.2M)(38.8M)(35.5M)(32.5M)
EBIT margin, %-8.9%6.8%12.9%2.4%-19.5%-65.1%-64.2%-59.1%
Interest income154.0K103.0K266.0K117.0K254.0K329.0K285.0K382.0K
Interest expense320.0K201.0K504.0K491.0K669.0K2.4M4.2M7.2M
Pre tax profit(6.9M)4.3M8.1M3.7M(12.7M)(41.8M)(39.2M)(39.2M)
Income tax expense637.0K826.0K1.0M771.0K1.1M1.3M(545.0K)932.0K
Net Income(7.5M)3.5M7.1M2.9M(13.8M)(43.1M)(38.6M)(40.1M)

Footer menu